Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Anne-Virginie Eggimann
CHIEF REGULATORY OFFICER, TESSERA THERAPUETICS
Women at the Crossroads in Gene Editing
Falk Ehmann, MD, PhD
HEAD OF INNOVATION AND DEVELOPMENT ACCELERATOR (IDEA), EUROPEAN MEDICINES AGENCY (EMA)
The Healthcare System of the Future: Emerging Technologies that Enable Drug Development and Patient Treatment
Zuid-Holland, Netherlands
Placeholder Photo
Nevan Elam
CEO, REZOLUTE BIO
Raising Capital in Tough Markets
Fiona Elwood, PhD
VP, DISEASE AREA STRONGHOLD LEAD, NEURODEGENERATION, JANSSEN
Treating Neurodegeneration by Targeting the Mechanisms of Aging
Boston, Massachusetts, United States
Mark Emalfarb
CHIEF EXECUTIVE OFFICER, DYADIC INTERNATIONAL, INC.
Dyadic International, Inc.
Jupiter, Florida, United States
YUSUF ERKUL, MD
CEO, KERNAL BIOLOGICS
Kernal Bio
Cambridge, Massachusetts, United States
Amit Etkin, MD
FOUNDER AND CHIEF EXECUTIVE OFFICER, ALTO NEUROSCIENCE
Beyond Drug Approvals: Clinical Trials that Actually Advance CNS Innovation
A New Framework for Applying AI to Mental Health Drug Development
Los Altos, California, United States
Seth Ettenberg
PRESIDENT AND CEO, BLUEROCK THERAPEUTICS
Creative funding options for biotechs
Placeholder Photo
Jay Evans
CHIEF SCIENTIFIC AND STRATEGY OFFICER, INIMMUNE CORPORATION
Inimmune Corporation
Missoula, Montana, United States
Andrew Fair
CFIUS STAFF CHAIR AND DIRECTOR, OFFICE OF INVESTMENT REVIEW & INVESTIGATION, U.S. DEPARTMENT OF THE TREASURY
Biotech and National Security: Considerations for Receiving Foreign Investment and CFIUS